Ghada M. Kunter, M.D.

Northwest Georgia Oncology Centers, P.C. Jasper Cancer Center 1020 J.L. White Drive
Suite 160
Jasper, GA 30143
Phone: (706) 692-0603
Fax: (678) 581-7109

Ghada M. Kunter, M.D. received her medical degree from the University of Mosul College of Medicine in Mosul, Iraq. With vast experience treating various types of cancers, Dr. Kunter is board certified in internal medicine, medical oncology.

Her academic background includes serving as a Clinical Fellow with the Winship Cancer Institute at Emory University’s Winship Cancer Institute and with the H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida.

Dr. Kunter provides patient-centered cancer care at NGOC’s Jasper Cancer Center.

Personal DataBirthplace: Mosul, Iraq
Medical EducationDoctor of Medicine
University of Mosul College of Medicine
Mosul, Iraq
June 1988
Postdoctoral TrainingRESIDENCY
OB/GYN
University of Mosul College of Medicine
Mosul, Iraq
July 1991 – June 1993

Internal Medicine/Pediatric
University of Kansas, School of Medicine
Wichita, Kansas
July 2000 – June 2004

FELLOWSHIP
Clinical Fellow,
Pediatric Hematology/Oncology
Washington University, School of Medicine
Children's Hospital in St. Louis
St. Louis, Missouri
July 2004 – June 2007

Postdoctoral Research Fellow, Adult Hematology
Washington University, School of Medicine
Children's Hospital in St. Louis
St. Louis, Missouri
July 2007 – June 2008

Instructor, Division of Hematology/Oncology
Washington University, School of Medicine
St. Louis, Missouri
July 2008 - June 2011

Clinical Fellow, Blood & Marrow Transplantation
H. Lee Moffitt Cancer Center and Research Institute
University of South Florida
Tampa, Florida
July 2011 – December 2012

Clinical Fellow, Adult Oncology
Winship Cancer Institute, Emory University, School of Medicine
Atlanta, Georgia
July 2013 – June 2015
Board CertificationAmerican Board of Internal Medicine, Medical Oncology, 2016
American Board of Internal Medicine, Pediatric Hematology/Oncology, 2013
American Board of Internal Medicine, Pediatrics, 2011
American Board of Internal Medicine, Internal Medicine, 2004
Medical LicensureState of Georgia, 2017
Major Research InterestsClinical Trials (Oncology & Hematology)
Awards & HonorsWinship 5K Delta myeloma scholar starting, 10/2014 - 07/2015
American Society of Hematology, abstract achieving award, 12/2012
American Society of Hematology, abstract achieving award, 12/2011
American Society of Hematology, abstract achieving award, 12/2007
Postdoctoral Fellowship, Hope Street Kids Grant and Fellowship Awards Recipient, 07/2007 - 07/2009
Postdoctoral Fellowship, American Society of Clinical Oncology, Young Investigator Award, 07/2007 - 07/2008
American Society of Hematology, abstract achieving award, 12/2006
Third Place award recipient, Annual Kansas Chapter ACP-ASIM associate competition, statistically showing that the "Measured Census" Does Not Accurately Reflect the Actual Workload, Sept 2002
United Nations, Multi-National Medical Award for medical effort and dedication during the Gulf War, 03/1991-08/1991
PublicationsHossain MS1, Kunter GM2, El-Najjar VF3, Jaye DL3, Al-Kadhimi Z1, Taofeek OK1, Li JM1, Waller EK1. PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in all-HSCT recipients.

Kunter G, Perkins J, Pidala J, Nishihori T, Fernandez H, Field T, Perez L, Locke F, Ayala E, Anasetti C. Pharmacokinetic ally-targeted BU and fludarabine as conditioning before allogenic hematopoietic cell transplantation for adults with ALL in first remission. Bone Marrow Transplantation, (2 Sept 2013) doi: 10.1038/bmt.2013.121.

Kunter G, Woloszynek JR, Link DC. A truncation mutant of Csf3r cooperates with PML-RARa to induce acute myeloid leukemia in mice. Exp Hematol. 10 Sept 2011.

Liu F*, Kunter G*, Krem M*, Eades W, Cain J, Tomasson M, Henninghausen L, Link DC. G-CSF receptor mutations found in patients with severe congenital neutropenia induce hematopoietic stern self-renewal that is mediated by STATS, JCI, 118:946-55, 2008.

Link DC, Kunter G, Kasai Y, Zhao Y, Miner T, McLellan MD, Ries RE, Kapur D, Nagarajan R, Dale DC, Bolyard AA, Boxer LA, Welte K, Zeidler C, Donadieu J, Bellane-Chantelot C, Vardiman JW, Caligiuri MA, Bloomfield CD, DiPersio JF, Tomasson MH, Graubert TA, Westervelt P, Watson M, Shannon W, Baty J, Mardis ER, Wilson RK, Ley TJ. Distinct patterns of mutations in de novo AML arising in the setting of severe congenital neutropenia. Blood, 110:1648-1655, 2007.

Mackie GC, Shulkin BL, Ribeiro RC, Worden FP, Gauger PG, Mody RJ, Connolly LP, Kunter G, Rodriguez-Galindo C, Wallis JW, Hurwitz CA, Schteingart DE. J Clin Endocrinol Metab. 2006 Jul; 91(7):2665-2671. Use of [18F] fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma.
Regional, National ContributionsPoster: 2012 BMT Tandem Meetings
Title: Survival Advantage of the Addition of Cell Therapy to Chemotherapy in Adult Patients with Relapsed AML after Allogeneic Hematopoietic Stem Cell Transplantation.

Poster: American Society of Hematology 2012
Title: Survival advantage of cell therapy over cytotoxic therapy alone in adult patients with relapsed AML after Allogeneic Hematopoietic Stem Cell Transplantation.

Poster: 2nd International Workshop on the Biology, Prevention and Treatment of Relapse after Hematopoietic Stem Cell Transplantation Meeting on November 5-6, 2012 at NIH Bethesda, MD
Title: Survival advantage of cell therapy over cytotoxic therapy alone in adult patients with relapsed AML after Allogeneic Hematopoietic Stem Cell Transplantation.

Oral Presentation: American Society of Hematology 2011
Title: Fludarabine and Targeted Busulfan is Safe and Effective Conditioning Before Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in First Remission.

Oral Presentation: American Society of Hematology 2010
Title: Alterations in the bone marrow microenvironment contribute to oxidative stress and DNA damage in hematopoietic stem/progenitors carrying a Csf3r truncation mutation.

Poster: American Society of Pediatric Hematology/Oncology 2009
Title: Molecular Mechanisms of Myelodysplastic Syndrome in Severe Congenital Neutropenia

Poster: American Society of Hematology 2009
Title: Increased ROS stress and alterations in the bone marrow microenvironment contribute to DNA damage in hematopoietic stem/progenitors carrying a Csf3r truncation mutation.

Poster: American Society of Hematology 2007
Title: G-CSFSR Mutations Present in Patients with Severe Congenital Neutropenia Cooperate with PML-RAR* to Induce Acute Myeloid Leukemia in Mice.

Oral Presentation: American Society of Hematology 2006
Title: G-CSF Receptor Mutations found in patients with Severe Congenital Neutropenia confer a strong competitive growth advantage at the Hematopoietic Stem Cell Level that is mediated by STAT5 activation.